Radebeul, Germany
INNOTERE GmbH, founded in 2005 and headquartered in Germany, is at the forefront of innovation in the fields of Health Care, Information Technology, and Manufacturing, specifically focusing on solutions for bone tissue repair and regeneration. Their slogan, "INNOTERE Biomaterial | Innovation for Tissue Engineering and Regeneration," encapsulates their commitment to advancing surgical materials.
The company specializes in developing cutting-edge bone cements based on calcium phosphates and poly (methyl methacrylate) to enhance implant fixation in osteoporotic bones. Additionally, INNOTERE is pioneering in resorbable biomimetic composites and bioactive cellular metal modifications for orthopedic applications. Their innovation prioritizes market needs and compatibility with minimally invasive surgical techniques, thanks to collaborations with biomaterial scientists and clinicians.
Their last significant financial backing was a Series B investment in July 2015 from the NIVALIS Group. Potential investors may find INNOTERE GmbH a promising opportunity due to its solid foundation and focus on addressing the growing demands in bone degeneration and surgical material advancements.
-logo.jpg "MBCP® Technology (Advanced Medical Solutions)"){kind=logo}
RevBio, Inc.